November 6, 2001
AmeriPath to Present at Investor Conference
FOR IMMEDIATE RELEASE

Contact: Gregory A. Marsh Michelle D. Getty Vice President & CFO Investor Relations AmeriPath, Inc. AmeriPath, Inc. 561-712-6211 561-712-6260 E-mail: invrel@ameripath.com

AMERIPATH, INC. TO PRESENT AT INVESTOR CONFERENCE

Riviera Beach, FL, November 6, 2001 – AmeriPath, Inc. (Nasdaq:PATH), one of the nation’s leading providers of anatomic pathology services, today announced it will participate in the CIBC World Markets 12th Annual Health Care Conference to be held at the The Plaza Hotel in New York City, New York. The AmeriPath presentation will be made by the Company’s Chairman and Chief Executive Officer, James C. New, and President, Brian C. Carr, on Wednesday, November 7, 2001, at 2:00 p.m. Eastern Time.

AmeriPath is a leading national provider of cancer diagnostics, genomics, and related information services. The Company’s extensive diagnostics infrastructure includes 425 pathologists and doctorate-level scientists, 42 independent pathology laboratories, the Center for Advanced Diagnostics (CAD), and Dermpath Diagnostics. CAD provides specialized diagnostic testing and information services including Fluorescence In-Situ Hybridization (FISH), Flow Cytometry, DNA Analysis, Polymerase Chain Reaction (PCR), Molecular Genetics, Cytogenetics, and HPV Typing. Dermpath Diagnostics, with 66 board-certified dermatopathologists, is the country’s leading provider of dermatopathology services in the growing skin diagnostic testing market. Additionally, AmeriPath provides clinical trial and research and development support to firms involved in developing new cancer and genomic diagnostics and therapeutics.